FluTrackers

Tracking Infectious Diseases since 2006

PayPal Verified medpedia.com

FluTrackers.com Inc. is a 501(c)(3) charity

Nederlandse taal Foro de Español de FluTrackers Francophones des FluTrackers Forum Italiano FluTrackers Latest Posts

www www.flutrackers.com



Go Back   FluTrackers > Local & Regional Communities and Organizations > CIDRAP

Reply
 
Thread Tools Search this Thread Display Modes
  #1  
Old January 24th, 2013, 06:17 PM
Shiloh's Avatar
Shiloh Shiloh is offline
Editor, Senior Moderator
 
Join Date: Feb 2008
Posts: 34,083
Default CIDRAP- Study puts global 2009 pandemic H1N1 infection rate at 24%

Source: http://www.cidrap.umn.edu/cidrap/con...n2412h1n1.html

Study puts global 2009 pandemic H1N1 infection rate at 24%

Robert Roos * News Editor

Jan 24, 2013 (CIDRAP News) – In a new analysis of serologic studies from 19 countries, researchers estimate that about 24% of the population were infected with the 2009 H1N1 influenza (pH1N1) virus during the first year of the pandemic, a finding modestly higher than what US health officials estimated in the immediate aftermath of the pandemic.

When the estimate is combined with recent estimates of the pandemic's death toll, it appears that about 1 in 5,000 (0.02%) of those infected with the virus died, says the report by a large team of researchers from the World Health Organization (WHO) and many other institutions. It was led by Maria D. Van Kerkhove, PhD, of the WHO and Imperial College London.

In accord with previous findings, the analysis showed that pH1N1 incidence varied widely by age-group, with the highest rates in children and the lowest in people 65 and older, who enjoyed a degree of protection by virtue of exposure to related H1N1 viruses much earlier in life. The study was published Jan 21 in Influenza and Other Respiratory Viruses.

The popular view of the 2009 pandemic is that it was fairly mild, even though it defied the typical seasonal flu age pattern by hitting younger adults more often than the elderly. But the authors note that its global impact is not well understood, largely because with the high volume of cases, the WHO recommended early on that testing focus on severe and fatal illnesses only. As a result, the numbers of cases and deaths reported to the WHO—fewer than 1 million and more than 18,449, respectively—are believed to be small fractions of the true numbers, they write.

They say their study is the first to assess pH1N1 serologic data by age-group from countries and regions around the world.

By searching the literature and contacting researchers, the authors found 27 published and unpublished serologic studies with data available by Jan 1, 2012. They looked for studies that assessed overall and age-stratified antibody titers against pH1N1, as measured by hemagglutination inhibition (HI) and microneutralization (MN) tests. Seropositivity was defined as an HI titer of at least 32 or an MN titer of at least 40.

The research includes serologic data from low-, middle-, and high-income countries, ranging from China, India, Iran, and Vietnam to Australia, France, Norway, and the United States.

To evaluate the cumulative incidence of pH1N1 infection, the team used studies that assessed the difference between pre-pandemic and post-pandemic prevalence of antibodies to the virus. They also estimated the prevalence of pre-existing cross-reactive antibodies to the virus by looking at studies that included serum samples collected before the pandemic, from 2004 to April 2009.

The overall pre-pandemic prevalence of pH1N1 antibodies was just 5% (95% confidence interval [CI], 3%-7%), the authors determined. The number varied considerably by age and was highest in the elderly (65 and older), at 14% (95% CI, 8%-24%).

For cumulative incidence of infection, the authors came up with an overall estimate of 24% (95% CI, 20%-27%). The figure was highest in children (ages 5 through 19), at 46% (95% CI, 36%-56%), and lowest in the elderly, at 11% (95% CI, 5%-18%).

In between were children 0 to 4 years old, 37% (36%-56%); adults 20 through 44, 20% (13%-26%); and those 45 through 64 years, 14% (9%-20%).

These numbers are, overall, moderately higher than estimates the US Centers for Disease Control and Prevention (CDC) made for the impact of the pandemic in the United States from April 2009 to April 2010. The agency estimated that 61 million Americans had been infected, or about 19.8% of the 2010 population of 308.7 million, as compared with 24% in the WHO study. The CDC said the total could have been anywhere from 43 million to 89 million, with 61 million as the midlevel estimate.

In addition, the CDC estimated that 25.7% of children ages 0 through 17 were infected, according to reports at the time. That compares with the WHO estimate of 37% for children through age 4 and 46% for those ages 5 through 19.

Also, the CDC put the adult infection rate at 18.5% for those ages 18 through 64, whereas the current study listed 20% for those 20 through 44 years old and 14% for those 45 through 64. And for the elderly, the CDC estimated a 15.8% infection rate, versus the global estimate of 11%.

The WHO researchers say their age-specific cumulative incidence findings were consistent across countries, which might have been strengthened because they carefully categorized their sera according to the timing of collection relative to the pandemic peak in each country.

If the findings in the 19 included countries are similar to the rest of the world—for which few data exist—and if recent pH1N1 mortality estimates from two research groups are confirmed by other studies, pH1N1 case-fatality rate would be less than .02%, the report says.

It cites in particular a study published last September in Lancet Infectious Diseases, in which a large international group of scientists estimated that the pandemic virus caused 201,200 respiratory-disease deaths and 83,300 cardiovascular deaths from April 2009 to August 2010.

In discussing possible limitations of the study, the authors said they found conflicting results when they assessed the potential impact of pH1N1 vaccination on their findings. Because of this, and because vaccine coverage in most countries was low when samples were collected, they believe the vaccine had little impact on their results.

"Our data demonstrates that approximately 24% of the populations of countries for which there are data were infected during the first wave of the pandemic, with incidence reaching 50% in school-age children," the authors conclude. They say their findings also point up the need to standardize seroepidemiologic studies and include them in pandemic preparedness plans.

Van Kerkhove MD, Hirve S, Koukounari A, et al. Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries. Influenza Other Respi Viruses 2013 (early online publication Jan 21) [Abstract]

See also:

April 20, 2010, CIDRAP News story about CDC estimate of H1N1 cases

Sep 2012 Lancet Infectious Diseases report

CDC estimates of pH1N1 cases, hospitalizations, and deaths from April 2009 to April 2010

Information on WHO initiative to estimate pH1N1 mortality

Mar 23, 2010, CIDRAP News story "Study: In life-years lost, H1N1 impact had sizable impact"
Reply With Quote
Reply


Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)
 
Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On


Disclaimers:

The reader is responsible for discerning the validity, factuality or implications of information posted here, be it fictional or based on real events. Moderators on this forum make every effort to review the material posted on this site however, it is not realistically possible for our staff to manually review each post.

The content of posts on this site, including but not limited to links to other web sites, are the expressed opinion of the original authors or posters and are not endorsed by, or representative of the opinions of, the owners or administration of this website. The posts on this website are the opinion of the specific author or poster and should not be construed as statements of advice or factual information.

Not all posts on this website are intended as truthful or factual assertion by their authors. NO posts on this website should be considered factual information on face value alone. Users are encouraged to USE DISCERNMENT and do their own follow up research while reading and posting on this website. FluTrackers.com Inc. reserves the right to make changes to, corrections and/or remove entirely at any time posts made on this website without notice. In addition, FluTrackers.com Inc. disclaims any and all liability for damages incurred directly or indirectly as a result of a post on this website.

This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall FluTrackers.com Inc. be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site.

Finally, FluTrackers.com Inc. reserves the right to delete, correct, or make changes to any post on this website without notice at any time for any reason.

Fair Use Notice:
This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to public health, civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed to those who have expressed a prior interest in receiving the included information for research and educational purposes.

In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 1 paragraph, and in no case more than 50% of the source material provide a link back to the original article and provide your original comments / criticism in your post with the article. Please remember you are responsible for what you post on the internet and you could be sued by the original copyright holder if you do not honor these rules.

If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright

we may be contacted concerning copyright matters at:

FluTrackers.com Inc.
c/o Sharon Sanders
1676 Hibiscus Avenue
Winter Park, Florida 32789
Phone: 407-745-1513
E-Mail: flutrackers@earthlink.net

In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein.

If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question.

All 3rd party material posted on this website is the copyright of the respective owners / authors. FluTrackers.com Inc. makes no claim of copyright on such material.

For more information please visit: http://www.law.cornell.edu/uscode/17/107.shtml

Please be aware any communications sent complaining about a post on this website may be posted publicly at the discretion of the administration.

FluTrackers Does Not Provide Any Medical Advice:

FluTrackers, Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster.

The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website.

By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.

By using and/or accessing this site, either passively or actively, you are agreeing to all of the above conditions. Also, by using and/or accessing this site, either passively or actively, you agree to conduct all business and legal affairs related to this website in the jurisdiction of Flutrackers.com Inc. which is registered in Central Florida, USA.

These Disclaimers are subject to change at anytime.

Email the Webmaster with questions or comments about this site at flutrackers@earthlink.net


All times are GMT -4. The time now is 02:51 AM.


H1N1 Influenza Swine Flu Avian Flu Infectious Diseases. Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2014, Jelsoft Enterprises Ltd.
Template-Modifications by TMS